Taking Aim at Alphaviruses
Alphaviruses are responsible for a considerable number of human and animal diseases. Infectious outbreaks can induce fever, malaise, and headaches, ...
Tag: Chikungunya
New Vaccine Development Platform Could Fight Deadly, Multi-Drug Resistant Bacteria
A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant bacteria, thanks ...
CHIKRisk: Mapping the Next Chikungunya Outbreak
A new computer application — called CHIKRisk — uses statistical modeling to help predict the risk of an outbreak of ...
DCN Diagnostics and E25Bio Partner on Point-of-Care Diagnostics
DCN Dx, a developer and manufacturer of rapid point-of-care diagnostic tests, and E25Bio, an MIT-spinoff diagnostics company from the Gehrke ...
Naval Research Laboratory Seeks to Advance Field Diagnostics of Infectious Agents
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
The Emergence of Usutu Virus in Europe
Researchers are taking stock of the emergence of Usutu virus in Europe, a mosquito-borne virus that circulates between birds. It ...
WHO Updates Blueprint List of Priority Diseases
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential ...
What Does Warming Planet Mean for Mosquito-Bourne Diseases?
Workers in Ecuador spray insecticide to kill Aedes aegypti mosquitoes, which spread dengue, chikungunya and Zika diseases. Credit: Dany Krom ...
MV-CHIKV Chikungunya Vaccine Clinical Trial Begins
A clinical trial of an experimental vaccine to prevent infection with chikungunya virus is now enrolling healthy adult volunteers at ...
U.S. Navy to Sponsor Study on Acute Febrile Illness in Latin America
The U.S. Naval Medical Research Unit No. 6 (NAMRU-6) is looking for a public academic institution for a collaborative acute ...
From Outbreak to Endemicity: The Risks of Fading Interest in Zika
Although cases of Zika virus infection appear to be decreasing, the mosquito-borne virus likely will become endemic in the Americas ...
PaxVax Announces Partnership with NIH and DOD for Chikungunya Vaccine Program
PaxVax last week announced a partnership with the National Institutes of Health (NIH) and United States Department of Defense (DoD) on its ...
RFP – Clinical Research Services Sought by NIH Vaccine Research Center
The Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) is soliciting for clinical ...
Identifying Potential Antivirals Against Chikungunya
Chikungunya virus has caused two recent massive outbreaks sickening millions of people. Now a team of researchers has shown that ...
The Impact of Vector-Borne Diseases on Global Health
The National Academies of Science, Engineering and Medicine (NASEM) Forum on Microbial Threats has released a new summary of its ...
Fever and Human Mobility in an Epidemic
Dengue fever is common in Iquitos, Peru, a densely packed city surrounded by the Amazon. With the imminent arrival of ...
CDC Establishing a Vector Control Unit in Puerto Rico
The Centers for Disease Control and Prevention has announced new funding efforts to strengthen the capacity to perform long-term vector control ...
Biosafety Guidelines for Working with Zika Virus
NIAID researcher conducts laboratory studies under the biosafety hood. Image: NIH/NIAID As the public health and research community mobilizes to ...
Novel Mechanisms to Block Chikungunya Virus
Scientists looking at the antiviral mechanisms of two previously identified human monoclonal antibodies have found they potently inhibit chikungunya virus ...
Single Vaccine for Chikungunya and Other Alphaviruses?
Washington University School of Medicine researchers have identified “broadly neutralizing” antibodies that protect against infection by multiple, distantly related alphaviruses – ...
